Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
14 hedge funds and large institutions have $3.7M invested in Orgenesis Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
10% less capital invested
Capital invested by funds: $4.12M → $3.7M (-$418K)
22% less funds holding
Funds holding: 18 → 14 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$47.4K |
| 2 |
BlackRock
New York
|
+$31K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$7.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
Venator Capital Management
Toronto,
Ontario, Canada
|
-$685K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$58K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$11K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
-$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.8K |
ORGS Hedge Fund Activity: Q4 2019 in Review
14 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q4 2019, worth a combined $3.7M — down 10% from $4.12M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ORGS and 1 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $47.4K. The largest seller was Venator Capital Management, exiting entirely with an estimated $685K sold.
- 14 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q4 2019, down from 18 in Q3 2019.
- Funds reported $3.7M of Orgenesis Inc. Common Stock stock for Q4 2019, down 10% quarter-over-quarter.
- 1 fund opened new Orgenesis Inc. Common Stock positions in Q4 2019 and 5 closed out, a net change of -4 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q4 2019 was Renaissance Technologies, an estimated $47.4K added.
- The largest Orgenesis Inc. Common Stock seller in Q4 2019 was Venator Capital Management, an estimated $685K sold.
Based on aggregated 13F filings for Q4 2019.